Molecular genetics of neurofibromatosis type 1 (NF1)

Journal of Medical Genetics

Volumn 33, Issue 1, 1996, Pages 2-17

  Shen, Ming Hong ^a,b   Harper, Peter S ^a   Upadhyaya, Meena ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Molecular genetics; Neurofibromatosis 1

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; NEUROFIBROMIN;

ALTERNATIVE RNA SPLICING; AUTOSOMAL DOMINANT DISORDER; CAFE AU LAIT SPOT; CHROMOSOME 17Q; EXON; GENE ISOLATION; HUMAN; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEQUENCE HOMOLOGY; SOMATIC MUTATION;

EID: 0030024492     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.33.1.2     Document Type: Review

References (19)

1. Riccardi VM. Neurofibromatosis: clinical heterogeneity. Curr Probl Cancer 1982;7:1-34.
2. Carey JC, Baty BJ, Johnson JP, Morrison T, Skolnick M, Kivlin J. The genetic aspects of neurofibromatosis. Ann NY Acad Sci 1986;486:45-56.
3. Stumpf DA, Alksne JF, Annegers JF, et al. Neurofibromatosis. NIH consensus development conference statement. Arch Neurol 1988;45:575-8.
4. Cawthon RM, Weiss R, Xu G, et al. A major segment of the neuronbromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
5. Viskochil D, Buchberg AM, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-92.
6. Wallace MR, Marchuk DA, Anderson LB, et al. Type 1 neuronbromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-6.
7. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuronbromatosis type 2. Nature 1993;363:515-21.
8. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-like, ezrin-like, radixin-like gene is a candidate for neurofibromatosis-2 tumor suppressor. Cell 1993;72:791-800.
9. Trattner A, David M, Hoda KE, Bendavid E, Sandbank M. Segment neurofibromatosis. J Am Acad Dermatol 1990;23:866-9.
10. Watson GH. Pulmonary stenosis, cafe-au-lait spots, and dull intelligence. Arch Dis Child 1967;42:303-7.
11. Allanson JE. Noonan syndrome. J Med Genet 1987;24:9-13.
12. Pulst SM, Riccardi VM, Fain P, Korenberg JR. Familial spinal neurofibromatosis: clinical and DNA linkage analysis. Neurology 1991;41:1923-7.
13. Brunner HG, Hulsebos T, Steijlen PM, der Rinderen DG, Steen AVD, Hamel BCJ. Exclusion of the neurofibromatosis locus in a family with inherited café-au-lait spots. Am J Med Genet 1993;46:472-4.
14. Purcell S, Dixon SL. Schwannomatosis. An unusual variant of neurofibromatosis or a distinct clinical entity. Arch Dermatol 1989;125:390-3.
15. Riccardi VM, Eichner JE. Neurofibromatosis: phenotype, natural history and Pathogensis. Baltimore: Johns Hopkins University Press, 1986.
16. Huson SM, Harper PS, Compton DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in South-East Wales. Brain 1988;111:1355-81.
17. Huson SM, Hughes RAC. The neurofibromatosis: a pathogenetic and clinical overview. London: Chapman & Hall, 1994.
18. Jadayel D, Fain P, Upadhyaya M, et al. Paternal origin of new mutations in Von Recklinghausen neurofibromatosis. Nature 1990;343:558-9.
19. Stephens K, Kayes L, Riccardi VM, Rising M, Sybert VP, Pagon RA. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet 1992;88:279-82.